|Event Date/Time: Oct 27, 2010||End Date/Time: Oct 29, 2010|
Amidst attrition challenges and pressures from stakeholders, the laurels are up for grabs for the next leaders in drug development. While the industry is struggling to achieve financial sustainability and operational viability, it is awaiting the leadership of a new bold visionary who will bring fundamental innovation to overhauling the research approaches of the past. When gearing up for the future, pharmaceutical and biopharmaceutical companies continue securing long-lasting lucrative partnerships along their value chains. Incorporating novel development paradigms and improving internal decision-making pave the way to shorter timelines and growing profit margins. Infusing the pipeline with talented manpower and reliable risk containment techniques leads the pharmaceutical industry into a new age of productivity.
In the competitive drug market, achieving excellence is possible through locking in profitable relationships with the most reliable, forward-thinking and innovative service partners. Combining cutting-edge technology solutions with solid management and far-sighted expert advice, drug development executives bring their companies closer to continuous commercial success.